En Es
Categorías

BioFire Diagnostics

BioFire Diagnostics

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based on a symptom-driven diagnostic method that combines a broad grouping of probable pathogenic causes into a single, rapid test. Its specialties include infectious disease diagnostics, multiplex PCR, real-tim ...
Productos Covid-19Resumen
Close

Covid-19 BioFire Diagnostics

Laboratorio clínico

Respiratory Panel
BioFire® Respiratory 2.1 (RP2.1) Panel (EUA)

The BioFire RP2.1 Panel (EUA) uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with respiratory infections. Fast and comprehensive, the BioFire RP2.1 Panel (EUA) offers a run time of about 45 minutes, enabling high efficiency and throughput on the BioFire® FilmArray® 2.0 and the BioFire® FilmArray® Torch Systems. Rapid respiratory PCR test results may enable better-informed diagnosis and treatment of patients. Quick turnaround on a broad menu of pathogens may also help clinicians make vital decisions regarding admission, isolation, cohorting, and additional diagnostic testing.
Mas detalles

PANEL RESPIRATORIO CON SARS-COV-2
BioFire Respiratory 2.1-EZ (RP2.1- EZ) Panel With SARS-CoV-2

El panel BioFire® Respiratory 2.1 (RP2.1) con SARSCoV-2, está diseñado para la detección del SARS-CoV2 y detecta 21 patógenos respiratorios adicionales para ayudar a los médicos a identificar rápidamente otras causas de enfermedades respiratorias.
Mas detalles
Close

Sobre BioFire Diagnostics

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based on a symptom-driven diagnostic method that combines a broad grouping of probable pathogenic causes into a single, rapid test. Its specialties include infectious disease diagnostics, multiplex PCR, real-time PCR instruments and reagents, hi-res melting instruments and kits, molecular diagnostics, and syndromic testing.

Actualizado

Joint Infection Tests
BioFire Joint Infection (JI) Panel

The BioFire Joint Infection (JI) Panel tests for a comprehensive grouping of Gram-positive and Gram-negative bacteria, yeast, and antimicrobial resistance genes commonly associated with joint infections. In about an hour, the BioFire JI Panel simultaneously targets a broad grouping of 31 causative pathogens and 8 antimicrobial resistance markers commonly associated with joint infections.
Mas detalles

Pneumonia Panel
BioFire FilmArray Pneumonia (PN) Panel

The BioFire Pneumonia Panel (PN) identifies 33 clinically relevant targets from sputum (including endotracheal aspirate) and bronchoalveolar lavage (including mini-BAL) samples. For 15 of the bacteria, the panel provides semi-quantitative results, which may help determine whether an organism is a colonizer or a pathogen. It delivers fast, accurate pathogen identification in about one hour, which may allow physicians to put patients on appropriate therapy quicker.
Mas detalles

PANEL RESPIRATORIO CON SARS-COV-2
BioFire Respiratory 2.1-EZ (RP2.1- EZ) Panel With SARS-CoV-2

El panel BioFire® Respiratory 2.1 (RP2.1) con SARSCoV-2, está diseñado para la detección del SARS-CoV2 y detecta 21 patógenos respiratorios adicionales para ayudar a los médicos a identificar rápidamente otras causas de enfermedades respiratorias.
Mas detalles

Laboratorio clínico

Joint Infection Tests
BioFire Joint Infection (JI) Panel

The BioFire Joint Infection (JI) Panel tests for a comprehensive grouping of Gram-positive and Gram-negative bacteria, yeast, and antimicrobial resistance genes commonly associated with joint infections. In about an hour, the BioFire JI Panel simultaneously targets a broad grouping of 31 causative pathogens and 8 antimicrobial resistance markers commonly associated with joint infections.
Mas detalles

Pneumonia Panel
BioFire FilmArray Pneumonia (PN) Panel

The BioFire Pneumonia Panel (PN) identifies 33 clinically relevant targets from sputum (including endotracheal aspirate) and bronchoalveolar lavage (including mini-BAL) samples. For 15 of the bacteria, the panel provides semi-quantitative results, which may help determine whether an organism is a colonizer or a pathogen. It delivers fast, accurate pathogen identification in about one hour, which may allow physicians to put patients on appropriate therapy quicker.
Mas detalles

PANEL RESPIRATORIO CON SARS-COV-2
BioFire Respiratory 2.1-EZ (RP2.1- EZ) Panel With SARS-CoV-2

El panel BioFire® Respiratory 2.1 (RP2.1) con SARSCoV-2, está diseñado para la detección del SARS-CoV2 y detecta 21 patógenos respiratorios adicionales para ayudar a los médicos a identificar rápidamente otras causas de enfermedades respiratorias.
Mas detalles

Respiratory Panel
BioFire® Respiratory 2.1 (RP2.1) Panel (EUA)

The BioFire RP2.1 Panel (EUA) uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with respiratory infections. Fast and comprehensive, the BioFire RP2.1 Panel (EUA) offers a run time of about 45 minutes, enabling high efficiency and throughput on the BioFire® FilmArray® 2.0 and the BioFire® FilmArray® Torch Systems. Rapid respiratory PCR test results may enable better-informed diagnosis and treatment of patients. Quick turnaround on a broad menu of pathogens may also help clinicians make vital decisions regarding admission, isolation, cohorting, and additional diagnostic testing.
Mas detalles

PRUEBA RÁPIDA DE ANTÍGENO PARA COVID-19
FilmArray EZ

El FilmArray EZ es un sistema aprobado según CLIA para pruebas moleculares cercanas al paciente que permite pruebas moleculares descentralizadas en toda una red de proveedores y ofrece una interfaz de usuario intuitiva y simplificada y un informe de resultados.
Mas detalles

Sistema de pruebas de diagnostico
BioFire® FilmArray® 2.0 System

El FilmArray 2.0 maneja hasta ocho instrumentos por computadora y puede analizar hasta 175 muestras por día. Sus capacidades de interfaz LIS permiten simplificar la solicitud de pruebas, disminuye los plazos de entrega y da una mayor exactitud al minimizar la entrada de datos.
Mas detalles

SISTEMA DE ACCESO ALEATORIO
BioFire® FilmArray® Torch System

FilmArray Torch es un sistema de acceso aleatorio, totalmente integrado, diseñado para satisfacerlas necesidades de pruebas de enfermedades infecciosas sindrómicas de un laboratorio, compatible con todos los paneles FilmArray existentes, que proporcionan resultados rápidos y exactos.
Mas detalles

Meningitis/Encephalitis (ME) Panel
BioFire® FilmArray® Meningitis/Encephalitis (ME) Panel

The BioFire ME Panel tests for a comprehensive set of 14 bacteria, viruses, and yeast. The BioFire ME Panel identifies the most common viral, bacterial, and yeast pathogens that cause infections in the central nervous system, which in some cases can be life-threatening.
Mas detalles

Rapid Diagnostic Test
BioFire® FilmArray® Blood Culture Identification Panels

The newly expanded and FDA-cleared BioFire® Blood Culture Identification 2 (BCID2) Panel tests for 43 targets associated with bloodstream infections, including gram-negative bacteria, gram-positive bacteria, yeast, and 10 antimicrobial resistance genes—all with one test and with results available in about an hour from positive blood culture. The panel features broadened inclusivity for Enterobacterales, new assays for fungal and anaerobic pathogens, and additional identification of coagulase-negative Staphylococcus species. The panel menu includes seven additional resistance genes, including carbapenemases and colistin resistance genes.
Mas detalles

Rapid Diagnostic Test
BioFire® FilmArray® Gastrointestinal (GI) Panel

The FilmArray Gastrointestinal (GI) Panel tests stool specimens for a comprehensive set of 22 common pathogens associated with gastroenteritis. Designed with the syndromic approach in mind, the panel combines a broad grouping of probable pathogenic causes into a single, rapid test.
Mas detalles

Software de laboratorio
BioFire® FilmArray® Link Software

El software FilmArray Link permite que el sistema FilmArray haga interfaz con un LIS, permitiendo que los resultados de los análisis sean transferidos electrónicamente. Las capacidades de interfaz LIS permiten un tiempo de respuesta más rápido y una mayor exactitud, mientras que el software optimiza el flujo de trabajo y asegura un manejo de datos eficiente.
Mas detalles
Derecho de autor © 2000-2024 TradeMed.com. Todos los derechos reservados. | Términos y condiciones